
They are: Johnson and Johnson & AstraZeneca.
The HSE has confirmed it’s been recommended that the age limit for two vaccines be lowered.
NIAC has recommended the AstraZeneca and Johnson and Johnson vaccines can be used in people in their 40s.
Health officials are expected to announce an updated decision on the rollout in the coming days.
The HSE’s Chief Clinical Officer, Colm Henry, says they’re considering the advice carefully.
Whilst, a Covid-19 vaccine from GlaxoSmithKline and Sanofi saw strong results from its phase 2 trial.
722 volunteers showed development of antibodies following a second injection in all age groups, with no safety concerns.
A larger trial will now start and the firms hope to get regulatory approval before the end of the year.